Chemistry
Global

Chemistry Experts

Julian Adams

Chief Executive Officer
Chemistry
Gamida Cell Ltd
Israel

Biography

Dr. Adams has more than 30 years of experience in drug discovery and development with a strong focus on cancer research. Dr. Adams joined Gamida Cell’s board of directors in 2016. Prior to being appointed CEO in November 2017, Dr. Adams served as chief scientific officer and president of Clal Biotechnology Industries. He was previously president of research and development at Infinity Pharmaceuticals. Prior to joining Infinity in 2003, Dr. Adams was the senior vice president of drug discovery and development at Millennium Pharmaceuticals, where he headed multiple global drug discovery and development programs, including the successful Velcade® (bortezomib) program. Dr. Adams also held senior positions in research and development at LeukoSite (acquired by Millennium) and at ProScript, as well as in medicinal chemistry at Boehringer Ingelheim, where he is credited with discovering Viramune® (nevirapine) for HIV. Dr. Adams has won several awards for his drug development efforts throughout his career, holds more than 40 patents from the United States Patent and Trademark Office (USPTO) and has authored more than 100 papers and book chapters in peer-reviewed journals. Dr. Adams received a B.S. from McGill University and a Ph.D. from the Massachusetts Institute of Technology. He also earned a Doctor of Science, honoris causa, from McGill University in 2012.

Research Interest

Chemistry 

Global Experts from Israel

Global Experts in Subject

Share This Profile
Recommended Conferences